<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04677296</url>
  </required_header>
  <id_info>
    <org_study_id>PR-17028</org_study_id>
    <nct_id>NCT04677296</nct_id>
  </id_info>
  <brief_title>Efficacy and Safety of &quot;VS002A&quot; With the Standard WHO-ORS in Non-cholera Acute Watery Diarrhea in Infants and Young Children</brief_title>
  <official_title>Clinical Trial to Compare the Efficacy and Safety of a Multiple Amino-acid Based ORS &quot;VS002A&quot; With the Standard WHO-ORS in the Management of Non-cholera Acute Watery Diarrhea in Infants and Young Children</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Entrinsic Bioscience Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>International Centre for Diarrhoeal Disease Research, Bangladesh</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Entrinsic Bioscience Inc.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Randomized double blinded clinical trial comparing amino acid based oral rehydration&#xD;
      solution/medical food and glucose-based oral rehydration solution is infectious diarrhea in&#xD;
      pediatric population&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 16, 2021</start_date>
  <completion_date type="Anticipated">May 2023</completion_date>
  <primary_completion_date type="Anticipated">March 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Randomized double blinded</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Duration of diarrhea in hospital (hours)</measure>
    <time_frame>5 days</time_frame>
    <description>number of hours of diarrhea after randomization</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Stool output</measure>
    <time_frame>1 day</time_frame>
    <description>Stool output in the 1st 24 hours of hospitalization (g/kg body wt.), divided into two 12-hour periods</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total stool output</measure>
    <time_frame>5 days</time_frame>
    <description>Total amount of stool output during the study</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ORS intake in the 1st 24 hours of hospitalization</measure>
    <time_frame>1 day</time_frame>
    <description>Amount of intervention drink consumed in the first 24 hours after randomization</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total ORS intake</measure>
    <time_frame>5 days</time_frame>
    <description>Amount of intervention drink consumed throughout the duration of the study</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Unscheduled IV (frequency/ORS group)</measure>
    <time_frame>5 days</time_frame>
    <description>Frequency of IV fluids between he 2 groups</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Treatment failure (frequency/ORS group)</measure>
    <time_frame>5 days</time_frame>
    <description>Frequency of treatment failures between the two groups</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Output and frequency of vomiting</measure>
    <time_frame>5 days</time_frame>
    <description>Amount and frequency of vomiting between the two groups</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in body weight (between pre-randomization and post-treatment)</measure>
    <time_frame>5 days</time_frame>
    <description>Body weight at randomization and post treatment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Urine output in the 1st 24 hours of hospitalization (g/kg body wt.)</measure>
    <time_frame>1 day</time_frame>
    <description>Amount of urine in the first 24 hours after randomization</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total urine output during hospitalization</measure>
    <time_frame>5 days</time_frame>
    <description>Total urine output (g/kg body wt.)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Documented infectious agent</measure>
    <time_frame>5 days</time_frame>
    <description>Stool culture and recording of infectious agent causing the diarrhea</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">312</enrollment>
  <condition>Diarrhea, Infantile</condition>
  <arm_group>
    <arm_group_label>VS002A</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Amino acid based ORS/medical food (VS002A). Initial treatment dosing with VS002A will be estimated using body weight in accordance with 5-10 ml/kg after each loose stool as per icddr,b guidelines, to maintain ongoing loss.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard WHO-ORS</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Standard WHO-ORS. Initial treatment dosing with WHO-ORS will be estimated using body weight in accordance with 5-10 ml/kg after each loose stool as per icddr,b guidelines, to maintain ongoing loss.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>VS002A</intervention_name>
    <description>Amino acid based ORS/Medical food</description>
    <arm_group_label>VS002A</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>WHO-ORS</intervention_name>
    <description>WHO Oral rehydration solution, which is glucose based</description>
    <arm_group_label>Standard WHO-ORS</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria:&#xD;
&#xD;
          1. Age: 6 months - 36 months,&#xD;
&#xD;
          2. Duration of diarrhea â‰¤48 hours,&#xD;
&#xD;
          3. Some dehydration (judged clinically according to the &quot;Dhaka method&quot;),&#xD;
&#xD;
          4. Written informed consent by either parent/guardian.&#xD;
&#xD;
        Exclusion criteria:&#xD;
&#xD;
          1. Severe malnutrition (Weight-for-length WLZ/WHZ/WAZ &lt;-3 or presence of nutritional&#xD;
             edema)&#xD;
&#xD;
          2. Patients with diarrhea due to cholera.&#xD;
&#xD;
          3. Systemic illness (e.g. Pneumonia, tuberculosis, enteric fever, meningitis etc.)&#xD;
&#xD;
          4. Bloody diarrhea&#xD;
&#xD;
          5. Any congenital anomaly or disorder (e.g. diagnosed inborn error of metabolism,&#xD;
             congenital cardiac disease, seizure disorders, hypothyroidism, Down's syndrome etc.)&#xD;
&#xD;
          6. Requirement of additional intravenous fluids after being provided with an IV for 4&#xD;
             hours on admission if severely dehydrated&#xD;
&#xD;
          7. Has documentation of taking antibiotic and/or antidiarrheal within the last 48 hours&#xD;
             prior to hospitalization.&#xD;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Measuring stool output on a diaper on female children will create a bias since it will be mixed with urine.</gender_description>
    <minimum_age>6 Months</minimum_age>
    <maximum_age>36 Months</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tahmeed Ahmed, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>International Centre for Diarrhoeal Disease Research, Bangladesh</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Tahmeed Ahmed, MD</last_name>
    <phone>+88(017)13093848</phone>
    <email>tahmeed@icddrb.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Pradip Bardhan, MD</last_name>
    <phone>+88(017)13093848</phone>
    <email>pradip.bardhan@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>ICDDR,B</name>
      <address>
        <city>Dhaka</city>
        <country>Bangladesh</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pradip Bardhan, MD</last_name>
      <phone>+88(017)13093848</phone>
      <email>pradip.bardhan@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Rina Das, MD</last_name>
      <phone>+8801716160451</phone>
      <email>rina.das@icddrb.org</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Bangladesh</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>November 17, 2020</study_first_submitted>
  <study_first_submitted_qc>December 15, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 21, 2020</study_first_posted>
  <last_update_submitted>August 16, 2021</last_update_submitted>
  <last_update_submitted_qc>August 16, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 20, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diarrhea</mesh_term>
    <mesh_term>Diarrhea, Infantile</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

